BiomX PHGE
NYSE PHGE
$0.14 0.00 (-1.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

BiomX (PHGE) Change in Account Payables (2019 - 2026)

BiomX (PHGE) posted Change in Account Payables of -$1.2 million for Q1 2026, down 129.5% sequentially from $4.1 million in Q4 2025, and down 11.62% YoY from -$1.4 million in Q1 2025.

BiomX (PHGE) Change in Account Payables (2019 - 2026) Analysis & Trends

BiomX has reported Change in Account Payables for 8 years, with the latest figure at -$1.2 million in Q1 2026.

  • Quarterly Change in Account Payables fell 11.62% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 490.53% YoY) and the FY2025 annual result came in at $1.2 million, up 225.81% from the prior year.
  • Change in Account Payables declined to -$1.2 million in Q1 2026 per PHGE's latest filing, from $4.1 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $4.1 million in Q4 2025 and troughed at -$3.1 million in Q3 2025.
  • A 5-year average of -$36937.5 and a median of $223000.0 in 2022 frame the typical range for Change in Account Payables.
  • The sharpest annual moves came in 2022 and 2025: Change in Account Payables sank 483.56% in 2022, then surged 2100.54% in 2025.
  • Over 5 years, Change in Account Payables stood at $1.5 million in 2022, then sank by 78.35% to $315000.0 in 2023, then slumped by 41.27% to $185000.0 in 2024, then soared by 2100.54% to $4.1 million in 2025, then tumbled by 129.5% to -$1.2 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$1.2 million, $4.1 million, and -$3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 BiomX 351,774.34 -816,225.66 - -1.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.20 Mn
Mar 31, 2026 -1.20 Mn
Dec 31, 2025 4.07 Mn
Dec 31, 2025 4.07 Mn
Sep 30, 2025 -3.13 Mn
Sep 30, 2025 -3.13 Mn
Jun 30, 2025 1.37 Mn
Jun 30, 2025 1.37 Mn
Mar 31, 2025 -1.08 Mn
Mar 31, 2025 -1.08 Mn
Dec 31, 2024 185,000.00
Dec 31, 2024 185,000.00
Sep 30, 2024 1.06 Mn
Sep 30, 2024 1.06 Mn
Jun 30, 2024 -454,000.00
Jun 30, 2024 -454,000.00
Dec 31, 2023 315,000.00
Dec 31, 2023 315,000.00
Sep 30, 2023 -1.11 Mn
Sep 30, 2023 -1.11 Mn